403 related articles for article (PubMed ID: 30505656)
1. Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.
Battogtokh G; Choi YS; Kang DS; Park SJ; Shim MS; Huh KM; Cho YY; Lee JY; Lee HS; Kang HC
Acta Pharm Sin B; 2018 Oct; 8(6):862-880. PubMed ID: 30505656
[TBL] [Abstract][Full Text] [Related]
2. A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator.
Jiang J; Stoyanovsky DA; Belikova NA; Tyurina YY; Zhao Q; Tungekar MA; Kapralova V; Huang Z; Mintz AH; Greenberger JS; Kagan VE
Radiat Res; 2009 Dec; 172(6):706-17. PubMed ID: 19929417
[TBL] [Abstract][Full Text] [Related]
3. The mitochondria-targeted imidazole substituted oleic acid 'TPP-IOA' affects mitochondrial bioenergetics and its protective efficacy in cells is influenced by cellular dependence on aerobic metabolism.
Maddalena LA; Ghelfi M; Atkinson J; Stuart JA
Biochim Biophys Acta Bioenerg; 2017 Jan; 1858(1):73-85. PubMed ID: 27836699
[TBL] [Abstract][Full Text] [Related]
4. OXPHOS-targeting drugs in oncology: new perspectives.
Kalyanaraman B; Cheng G; Hardy M; You M
Expert Opin Ther Targets; 2023; 27(10):939-952. PubMed ID: 37736880
[TBL] [Abstract][Full Text] [Related]
5. Targeting mitochondria.
Hoye AT; Davoren JE; Wipf P; Fink MP; Kagan VE
Acc Chem Res; 2008 Jan; 41(1):87-97. PubMed ID: 18193822
[TBL] [Abstract][Full Text] [Related]
6. Delocalized Lipophilic Cation Triphenyl Phosphonium: Promising Molecule for Mitochondria Targeting.
Pawar A; Korake S; Pawar A; Kamble R
Curr Drug Deliv; 2023; 20(9):1217-1223. PubMed ID: 35619273
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the mitochondria-targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases.
James AM; Sharpley MS; Manas AR; Frerman FE; Hirst J; Smith RA; Murphy MP
J Biol Chem; 2007 May; 282(20):14708-18. PubMed ID: 17369262
[TBL] [Abstract][Full Text] [Related]
8. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK
Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308
[TBL] [Abstract][Full Text] [Related]
9. Triphenylphosphonium-conjugated glycol chitosan microspheres for mitochondria-targeted drug delivery.
Lee YH; Park HI; Chang WS; Choi JS
Int J Biol Macromol; 2021 Jan; 167():35-45. PubMed ID: 33227331
[TBL] [Abstract][Full Text] [Related]
10. Baicalein abrogates reactive oxygen species (ROS)-mediated mitochondrial dysfunction during experimental pulmonary carcinogenesis in vivo.
Naveenkumar C; Raghunandhakumar S; Asokkumar S; Devaki T
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):270-81. PubMed ID: 23061789
[TBL] [Abstract][Full Text] [Related]
11. Stability of Phenyl-Modified Triphenylphosphonium Conjugates and Interactions with DTPA.
Gruenwald HK; Kerns RJ
ACS Omega; 2022 Dec; 7(51):48332-48339. PubMed ID: 36591157
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Mitochondrial Oxidative Stress in the Brain of a Transgenic Mouse Model of Alzheimer's Disease by in vitro Electron Paramagnetic Resonance Spectroscopy.
Manabe T; Matsumura A; Yokokawa K; Saito T; Fujikura M; Iwahara N; Matsushita T; Suzuki S; Hisahara S; Kawamata J; Suzuki H; Emoto MC; Fujii HG; Shimohama S
J Alzheimers Dis; 2019; 67(3):1079-1087. PubMed ID: 30714961
[TBL] [Abstract][Full Text] [Related]
13. A new triphenylphosphonium-conjugated amphipathic cationic peptide with improved cell-penetrating and ROS-targeting properties.
Ishkaeva RA; Salakhieva DV; Garifullin R; Alshadidi R; Laikov AV; Yergeshov AA; Kamalov MI; Abdullin TI
Curr Res Pharmacol Drug Discov; 2023; 4():100148. PubMed ID: 36593927
[TBL] [Abstract][Full Text] [Related]
14. The targeted anti-oxidant MitoQ causes mitochondrial swelling and depolarization in kidney tissue.
Gottwald EM; Duss M; Bugarski M; Haenni D; Schuh CD; Landau EM; Hall AM
Physiol Rep; 2018 Apr; 6(7):e13667. PubMed ID: 29611340
[TBL] [Abstract][Full Text] [Related]
15. Triphenylphosphonium (TPP)-Based Antioxidants: A New Perspective on Antioxidant Design.
Wang JY; Li JQ; Xiao YM; Fu B; Qin ZH
ChemMedChem; 2020 Mar; 15(5):404-410. PubMed ID: 32020724
[TBL] [Abstract][Full Text] [Related]
16. Small molecules as therapeutic drugs for Alzheimer's disease.
Oliver DMA; Reddy PH
Mol Cell Neurosci; 2019 Apr; 96():47-62. PubMed ID: 30877034
[TBL] [Abstract][Full Text] [Related]
17. Knockout of mitochondrial voltage-dependent anion channel type 3 increases reactive oxygen species (ROS) levels and alters renal sodium transport.
Zou L; Linck V; Zhai YJ; Galarza-Paez L; Li L; Yue Q; Al-Khalili O; Bao HF; Ma HP; Thai TL; Jiao J; Eaton DC
J Biol Chem; 2018 Feb; 293(5):1666-1675. PubMed ID: 29180450
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II.
Dong LF; Jameson VJ; Tilly D; Cerny J; Mahdavian E; Marín-Hernández A; Hernández-Esquivel L; Rodríguez-Enríquez S; Stursa J; Witting PK; Stantic B; Rohlena J; Truksa J; Kluckova K; Dyason JC; Ledvina M; Salvatore BA; Moreno-Sánchez R; Coster MJ; Ralph SJ; Smith RA; Neuzil J
J Biol Chem; 2011 Feb; 286(5):3717-28. PubMed ID: 21059645
[TBL] [Abstract][Full Text] [Related]
19. Cell-permeable, mitochondrial-targeted, peptide antioxidants.
Szeto HH
AAPS J; 2006 Apr; 8(2):E277-83. PubMed ID: 16796378
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Conjugation Density of Triphenylphosphonium Cation on the Mitochondrial Targeting of Poly(amidoamine) Dendrimers.
Bielski ER; Zhong Q; Brown M; da Rocha SR
Mol Pharm; 2015 Aug; 12(8):3043-53. PubMed ID: 26158804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
